Exhibit 99.1

                                  Press Release
                      Press Advisory From EDG Capital, Inc.

NEW YORK--(BUSINESS WIRE)--July 10, 2001--Isotope Solutions Inc. (ISI), a
wholly-owned subsidiary of EDG Capital, Inc. (OTCBB: EDGN - news), announced
today that Dr. Ira Braunschweig, director of New York Medical Oncology, PC,
d/b/a Center for Medical Oncology, an ISI-managed medical group specializing in
medical oncology and hematology, is leaving the Center to accept a position at
Brooklyn Hospital.

"This announcement is consistent with our efforts to further de-emphasize our
medical management posture," said Jack Schwartzberg, Chief Executive Officer,
President and Chairman of EDG Capital, Inc. "We intend to cover our medical
oncology needs from third party medical groups practicing in the Garden City,
New York area."

Through its wholly-owned subsidiary, Isotope Solutions, Inc., EDG Capital is
engaged in the research, development and testing of nuclear pharmaceuticals for
therapeutic use in the treatment of the most lethal forms of cancer.
Internationally renowned clinicians, who are under management contracts with
Isotope Solutions Inc., conduct research for the company.

- --------------

Contact:

     EDG CAPITAL, INC.
     Shragie David Aranoff, V.P.
     516/222-5154

                or

     Rubenstein Associates, Inc.
     Public Relations
     212/843-8049
     Patricia Amerman